Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-29 Sale | 2024-07-29 5:24 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 2,251 | $5.9203 | $13,327 | 229,398 (Indirect Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:50 pm | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel | 17,088 | $4.2903 | $73,313 | 196,825 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:48 pm | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer | 16,727 | $4.2997 | $71,921 | 129,789 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:47 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 55,172 | $4.193 | $231,339 | 1,871,730 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:46 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 14,700 | $4.3124 | $63,393 | 231,649 (Indirect Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:46 pm | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 17,411 | $4.2145 | $73,379 | 313,569 (Direct) | View |
| 2023-08-21 Sale | 2023-08-23 4:23 pm | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer | 3,724 | $5.84 | $21,748 | 113,816 (Direct) | View |
| 2023-08-10 Sale | 2023-08-11 4:36 pm | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 6,500 | $6.0537 | $39,349 | 29,328 (Direct) | View |
| 2023-07-28 Sale | 2023-08-01 4:30 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 2,212 | $6.3041 | $13,945 | 121,349 (Indirect Direct) | View |
| 2023-06-15 Sale | 2023-06-20 4:34 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 16,000 | $6.2944 | $100,710 | 123,561 (Indirect Direct) | View |
| 2023-06-13 Sale | 2023-06-15 4:20 pm | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel | 14,600 | $6.5585 | $95,754 | 88,913 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 6:26 pm | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel | 16,738 | $6.2476 | $104,572 | 103,513 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 6:26 pm | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer | 11,833 | $6.2636 | $74,117 | 117,540 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 6:25 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 44,964 | $6.2404 | $280,594 | 1,476,902 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 6:25 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 13,934 | $6.2684 | $87,344 | 139,561 (Indirect Direct) | View |
| 2023-03-02 Sale | 2023-03-06 6:24 pm | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 16,777 | $6.2338 | $104,584 | 205,980 (Direct) | View |
| 2022-12-15 Sale | 2022-12-16 4:38 pm | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel | 8,000 | $7.0087 | $56,070 | 87,551 (Direct) | View |
| 2022-12-05 Sale | 2022-12-07 5:58 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 95,900 | $10.62 | $1,018,282 | 1,482,231 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-22 Option Award | 2024-05-24 4:43 pm | N/A 2034-05-21 | Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director | 62,089 | $0 | 104,327 (Direct) | View |
| 2024-05-17 Option Award | 2024-05-21 4:55 pm | N/A 2034-05-16 | Vanda Pharmaceuticals Inc. | VNDA | Honore Tage Director | 58,107 | $0 | 101,822 (Direct) | View |
| 2024-05-17 Option Award | 2024-05-21 4:53 pm | N/A 2034-05-16 | Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director | 58,107 | $0 | 155,807 (Direct) | View |
| 2024-05-17 Option Award | 2024-05-21 4:53 pm | N/A 2034-05-16 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 58,107 | $0 | 87,435 (Direct) | View |
| 2024-05-17 Option Award | 2024-05-21 4:52 pm | N/A 2034-05-16 | Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director | 58,107 | $0 | 97,420 (Direct) | View |
| 2024-02-16 Option Award | 2024-02-21 4:53 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel | 125,000 | $0 | 213,913 (Direct) | View |
| 2024-02-16 Option Award | 2024-02-21 4:52 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer | 32,700 | $0 | 146,516 (Direct) | View |
| 2024-02-16 Option Award | 2024-02-21 4:52 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 125,000 | $0 | 246,349 (Direct) | View |
| 2024-02-16 Option Award | 2024-02-21 4:52 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 450,000 | $0 | 1,926,902 (Direct) | View |
| 2024-02-16 Option Award | 2024-02-21 4:50 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 125,000 | $0 | 330,980 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:20 pm | N/A 2033-06-07 | Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director | 51,267 | $0 | 73,273 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:19 pm | N/A 2033-06-07 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 51,267 | $0 | 69,788 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:19 pm | N/A 2033-06-07 | Vanda Pharmaceuticals Inc. | VNDA | Honore Tage Director | 51,267 | $0 | 77,675 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:18 pm | N/A 2033-06-07 | Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director | 51,267 | $0 | 131,660 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:17 pm | N/A 2033-06-07 | Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director | 51,267 | $0 | 76,198 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:50 pm | N/A 2033-03-14 | Vanda Pharmaceuticals Inc. | VNDA | Honore Tage Director | 77,684 | $0 | 77,684 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 6:11 pm | N/A 2033-02-15 | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel | 110,200 | $0 | 197,751 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 6:11 pm | N/A 2033-02-15 | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer | 110,200 | $0 | 206,873 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 6:10 pm | N/A 2033-02-15 | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 390,000 | $0 | 1,796,866 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 6:09 pm | N/A 2033-02-15 | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 110,200 | $0 | 230,995 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 6:08 pm | N/A 2033-02-15 | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 110,200 | $0 | 300,257 (Direct) | View |
| 2022-12-05 Exercise | 2022-12-07 5:58 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 150,000 | $3.12 | 1,482,231 (Direct) | View |
| 2022-12-05 Exercise | 2022-12-07 5:58 pm | N/A 2022-12-06 | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 150,000 | $0 | 1,482,231 (Direct) | View |